Skip to main content
Erschienen in: International Journal of Hematology 4/2011

01.10.2011 | Original Article

An evaluation of peripherally inserted central venous catheters for children with cancer requiring long-term venous access

verfasst von: Naoki Hatakeyama, Tsukasa Hori, Masaki Yamamoto, Nobuo Mizue, Natsuko Inazawa, Keita Igarashi, Hiroyuki Tsutsumi, Nobuhiro Suzuki

Erschienen in: International Journal of Hematology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Long-term venous access is essential when treating malignant diseases. We reviewed our experience with peripherally inserted central venous catheters (PICC) in children suffering from various malignancies with regard to catheter life, reasons for removal, and complications. Ninety-three PICCs were inserted in 78 children. Median catheter life was 162 days (range 6–575 days) with a total of 16,266 catheter days. Seventy-five PICCs (80.6%) had been placed until the elective removal or patients’ death, whereas 18 PICCs (19.4%) were removed due to PICC-related complications; a rate of 1.11 per 1,000 catheter days. Complications requiring removal of PICCs included infection (n = 12), occlusion (n = 3), dislodgement (n = 2), and phlebitis (n = 1) with rates of 0.74, 0.18, 0.12 and 0.06 per 1,000 catheter days, respectively. We conclude that PICC provides reliable long-term intravenous access in children suffering from malignancies.
Literatur
3.
Zurück zum Zitat Ryder MA. Peripheral access options. Surg Oncol Clin N Am. 1995;4:395–427.PubMed Ryder MA. Peripheral access options. Surg Oncol Clin N Am. 1995;4:395–427.PubMed
4.
Zurück zum Zitat Cardella JF, Cardella K, Bacci N, Fox PS, Post JH. Cumulative experience with 1, 273 peripherally inserted central catheters at a single institution. J Vasc Interv Radiol. 1996;7:5–13.CrossRefPubMed Cardella JF, Cardella K, Bacci N, Fox PS, Post JH. Cumulative experience with 1, 273 peripherally inserted central catheters at a single institution. J Vasc Interv Radiol. 1996;7:5–13.CrossRefPubMed
5.
Zurück zum Zitat Walshe LJ, Malak SF, Eagan J, Sepkowitz KA. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol. 2002;20:3276–81.CrossRefPubMed Walshe LJ, Malak SF, Eagan J, Sepkowitz KA. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol. 2002;20:3276–81.CrossRefPubMed
6.
Zurück zum Zitat Yap YS, Karapetis C, Lerose S, Iyer S, Koczwara B. Reducing the risk of peripherally inserted central catheter line complications in the oncology setting. Eur J Cancer Care. 2006;15:342–7.CrossRef Yap YS, Karapetis C, Lerose S, Iyer S, Koczwara B. Reducing the risk of peripherally inserted central catheter line complications in the oncology setting. Eur J Cancer Care. 2006;15:342–7.CrossRef
7.
Zurück zum Zitat Matsuzaki A, Suminoe A, Koga Y, Hatano M, Hattori S, Hara T. Long-term use of peripherally inserted central venous catheters for cancer chemotherapy in children. Support Care Cancer. 2006;14:153–60.CrossRefPubMed Matsuzaki A, Suminoe A, Koga Y, Hatano M, Hattori S, Hara T. Long-term use of peripherally inserted central venous catheters for cancer chemotherapy in children. Support Care Cancer. 2006;14:153–60.CrossRefPubMed
8.
Zurück zum Zitat Shen G, Gao Y, Wang Y, Mao B, Wang X. Survey of the long-term use of peripherally inserted central venous catheters in children with cancer: experience in a developing country. J Pediatr Hematol Oncol. 2009;31:489–92.CrossRefPubMed Shen G, Gao Y, Wang Y, Mao B, Wang X. Survey of the long-term use of peripherally inserted central venous catheters in children with cancer: experience in a developing country. J Pediatr Hematol Oncol. 2009;31:489–92.CrossRefPubMed
9.
Zurück zum Zitat Abedin S, Kapoor G. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer. Pediatr Blood Cancer. 2008;51:251–5.CrossRefPubMed Abedin S, Kapoor G. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer. Pediatr Blood Cancer. 2008;51:251–5.CrossRefPubMed
10.
Zurück zum Zitat Donowitz GR, Maki DG, Crnich CJ, Pappas PG, Rolston KV. Infections in the neutropenic patient—new views of an old problem. Hematology Am Soc Hematol Educ Program 2001; 113–39. Donowitz GR, Maki DG, Crnich CJ, Pappas PG, Rolston KV. Infections in the neutropenic patient—new views of an old problem. Hematology Am Soc Hematol Educ Program 2001; 113–39.
11.
Zurück zum Zitat Bethune K, Allwood M, Grainger C, Wormleighton C. Use of filters during the preparation and administration of parenteral nutrition: position paper and guidelines prepared by a British pharmaceutical nutrition group working party. Nutrition. 2001;17:403–8.CrossRefPubMed Bethune K, Allwood M, Grainger C, Wormleighton C. Use of filters during the preparation and administration of parenteral nutrition: position paper and guidelines prepared by a British pharmaceutical nutrition group working party. Nutrition. 2001;17:403–8.CrossRefPubMed
12.
Zurück zum Zitat Ball PA. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care. 2003;6:319–25.PubMed Ball PA. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care. 2003;6:319–25.PubMed
13.
Zurück zum Zitat O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol. 2002;23:759–69.CrossRefPubMed O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol. 2002;23:759–69.CrossRefPubMed
14.
Zurück zum Zitat Friedland G. Infusion-related phlebitis—is the in-line filter the solution? N Engl J Med. 1985;312:113–5.CrossRefPubMed Friedland G. Infusion-related phlebitis—is the in-line filter the solution? N Engl J Med. 1985;312:113–5.CrossRefPubMed
15.
Zurück zum Zitat Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol. 2005;16:648–54.CrossRefPubMed Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol. 2005;16:648–54.CrossRefPubMed
16.
Zurück zum Zitat Cesaro S, Tridello G, Cavaliere M, Magagna L, Gavin P, Cusinato R, et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. J Clin Oncol. 2009;27:2059–65.CrossRefPubMed Cesaro S, Tridello G, Cavaliere M, Magagna L, Gavin P, Cusinato R, et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. J Clin Oncol. 2009;27:2059–65.CrossRefPubMed
Metadaten
Titel
An evaluation of peripherally inserted central venous catheters for children with cancer requiring long-term venous access
verfasst von
Naoki Hatakeyama
Tsukasa Hori
Masaki Yamamoto
Nobuo Mizue
Natsuko Inazawa
Keita Igarashi
Hiroyuki Tsutsumi
Nobuhiro Suzuki
Publikationsdatum
01.10.2011
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 4/2011
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-011-0928-2

Weitere Artikel der Ausgabe 4/2011

International Journal of Hematology 4/2011 Zur Ausgabe

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.